Research Article

Synovial Sarcoma of the Head and Neck: A Single Institution Review

Table 2

Comparison of median survival times.

VariableMedian PFS duration, yearsLog-rank test valueMedian OS duration, yearsLog-rank test value

Sex
 Male5.410.21NA0.87
 Female3.47NA
Race
 WhiteNA0.387.280.09
 Other4.18NA
Tumor size
 ≥5 cm3.330.008NA0.78
 <5 cmNANA
Subtype
 Monophasic4.170.7457.91.00
 BiphasicNANA
 Poorly differentiated5.417.22
Surgical margin
 PositiveNA0.52NA0.98
 MarginNANA
Fusion gene
 Present4.02NA
Site
 Neck3.470.047.280.27
 OtherNANA
Treatment
 Definitive local therapy5.410.78NA0.80
 Local + systemic therapy4.58NA

Note. “NA” indicates that median survival was not reached; PFS: progression-free survival; OS: overall survival.